ArticleJournal of oncology2022

APOBEC3B and CD274 as Combined Biomarkers for Predicting Response to Immunotherapy in Urothelial Carcinoma of the Bladder.

Chuanhao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.